UnitedHealth Shares Plunge as Government Targets Medicare Fraud and Lawmakers Push Medicare for All

UnitedHealth Group shares suffered another significant decline on Thursday, extending a volatile week for the healthcare giant. The stock fell 7.1% in afternoon trading, contributing to a 20.1% drop over the past five business days. This downturn coincides with a broader selloff in health-insurance and biopharmaceutical equities, driven by new regulatory threats and legislative proposals.

The primary catalyst for the investor anxiety is a proposal by the Centers for Medicare and Medicaid Services, announced on Monday, to implement stricter rules aimed at preventing fraud within government-funded healthcare programs, including Medicare. Raymond James analyst Chris Meekins described the move as a “potentially significant expansion of federal oversight across federally funded health programs.”

Particular concern surrounds the new auditing standards for diagnosis codes. There are documented fears that insurers engage in “upcoding,” a practice where patients are recorded as having more severe conditions than they actually do to secure higher payments from Medicare. The new rules would increase scrutiny on how these codes are assigned and verified.

Peers in the industry have also seen their valuations shrink. Humana shares tumbled 15.4% over the last five days, while CVS Health, which operates the Aetna insurance arm, slid 11.7% in the same period.

Beyond immediate regulatory changes, market participants are also pricing in the long-term risks associated with political efforts to expand public healthcare. Senator Bernie Sanders and Representative Hakeem Jeffries, the incoming Speaker of the House, have renewed calls for Medicare for All. Unlike proposals that would create a new single-payer system from scratch, these plans focus on incremental expansions, such as lowering the eligibility age from 65 to 55 and including routine dental, hearing, and vision care in traditional Medicare.

William Blair analyst Ryan Daniels noted that investors are currently factoring in the “headline risk” of these legislative movements, even though the likelihood of such policies taking effect remains years away.

Leave a Reply

Your email address will not be published. Required fields are marked *